Simplex Trading’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Hold |
0
| – | – | – | 10435 |
|
|
2025
Q4 | – | Sell |
-147,300
| Closed | -$2.03M | – | 10259 |
|
|
2025
Q3 | $2.54M | Buy |
147,300
+70,523
| +92% | +$869K | 0.06% | 2085 |
|
|
2025
Q2 | $720K | Sell |
76,777
-64,490
| -46% | -$530K | 0.02% | 3135 |
|
|
2025
Q1 | $1M | Buy |
141,267
+30,736
| +28% | +$310K | 0.04% | 2706 |
|
|
2024
Q4 | $1.29M | Buy |
110,531
+31,537
| +40% | +$492K | 0.04% | 2603 |
|
|
2024
Q3 | $1.62M | Buy |
78,994
+38,206
| +94% | +$881K | 0.05% | 2458 |
|
|
2024
Q2 | $912K | Sell |
40,788
-23,885
| -37% | -$569K | 0.03% | 3016 |
|
|
2024
Q1 | $1.78M | Buy |
64,673
+52,922
| +450% | +$1.47M | 0.05% | 2524 |
|
|
2023
Q4 | $358K | Buy |
+11,751
| New | +$338K | 0.01% | 4041 |
|
|
2023
Q3 | – | Sell |
-36,386
| Closed | -$1.41M | – | 10192 |
|
|
2023
Q2 | $1.48M | Buy |
36,386
+30,490
| +517% | +$1.24M | 0.06% | 2222 |
|
|
2023
Q1 | $219K | Buy |
5,896
+4,047
| +219% | +$159K | 0.01% | 4217 |
|
|
2022
Q4 | $64K | Sell |
1,849
-195
| -10% | -$9.27K | ﹤0.01% | 5568 |
|
|
2022
Q3 | $114K | Buy |
+2,044
| New | +$127K | ﹤0.01% | 5340 |
|
|
2022
Q2 | – | Sell |
-860
| Closed | -$43.7K | – | 11336 |
|
|
2022
Q1 | $62K | Sell |
860
-1,483
| -63% | -$126K | ﹤0.01% | 6837 |
|
|
2021
Q4 | $277K | Sell |
2,343
-5,492
| -70% | -$688K | 0.01% | 4691 |
|
|
2021
Q3 | $1.34M | Buy |
7,835
+7,348
| +1,509% | +$1.11M | 0.05% | 2678 |
|
|
2021
Q2 | $78K | Sell |
487
-1,190
| -71% | -$92.7K | ﹤0.01% | 7081 |
|
|
2021
Q1 | $134K | Buy |
+1,677
| New | +$113K | 0.01% | 5339 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 9233 |
|
|
2020
Q3 | – | Sell |
-25,112
| Closed | -$524K | – | 8714 |
|
|
2020
Q2 | $527K | Sell |
25,112
-3
| -0% | -$51 | 0.03% | 2836 |
|
|
2020
Q1 | $307K | Buy |
+25,115
| New | +$338K | 0.02% | 3135 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 8207 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 8168 |
|
|
2019
Q2 | – | Sell |
-18,029
| Closed | -$283K | – | 8022 |
|
|
2019
Q1 | $307K | Buy |
18,029
+14,361
| +392% | +$214K | 0.03% | 3173 |
|
|
2018
Q4 | $50K | Sell |
3,668
-11,047
| -75% | -$205K | ﹤0.01% | 4527 |
|
|
2018
Q3 | $421K | Sell |
14,715
-9,324
| -39% | -$271K | 0.02% | 2815 |
|
|
2018
Q2 | $657K | Buy |
24,039
+3,162
| +15% | +$76.6K | 0.04% | 2190 |
|
|
2018
Q1 | $440K | Sell |
20,877
-26,841
| -56% | -$660K | 0.04% | 777 |
|
|
2017
Q4 | $917K | Buy |
47,718
+42,202
| +765% | +$974K | 0.06% | 428 |
|
|
2017
Q3 | $137K | Buy |
+5,516
| New | +$104K | 0.01% | 1469 |
|
|
2017
Q2 | – | Sell |
-5,920
| Closed | -$82.7K | – | 6944 |
|
|
2017
Q1 | $83K | Buy |
+5,920
| New | +$79.4K | 0.01% | 1919 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
